229
Views
8
CrossRef citations to date
0
Altmetric
Review

Cell adhesion molecules in Alzheimer’s disease

&
Pages 65-77 | Published online: 05 Jul 2012

References

  • LeyKLaudannaCCybulskyMINoursharghSGetting to the site of inflammation: the leukocyte adhesion cascade updatedNat Rev Immunol20077967868917717539
  • BevilacquaMPNelsonRMSelectinsJ Clin Invest19939123793877679406
  • BuhrerCHeroldRStibenzDHenzeGObladenMCerebrospinal fluid soluble L-selectin (sCD62L) in meningoencephalitisArch Dis Child19967442882928669926
  • Dore-DuffyPNewmanWBalabanovRCirculating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activityAnn Neurol199537155627529475
  • WhalenMJCarlosTMKochanekPMSoluble adhesion molecules in CSF are increased in children with severe head injuryJ Neurotrauma199815107777879814634
  • GearingAJNewmanWCirculating adhesion molecules in diseaseImmunol Today199314105065127506035
  • HynesROIntegrins: bidirectional, allosteric signaling machines. CellSeptember 2020021106673687
  • ReichardtLFProkopAIntroduction: The role of extracellular matrix in nervous system development and maintenance. Developmental neurobiologyNov20117111883888
  • WuXReddyDSIntegrins as receptor targets for neurological disordersJ Pharmacol Pharmacother201213416881
  • EvansBJMcDowallATaylorPCHoggNHaskardDOLandis RC Shedding of lymphocyte function-associated antigen-1 (LFA-1) in a human inflammatory responseBlood5 1, 200610793593359916418329
  • MarchettiPJO’ConnorPCellular adhesion molecules in neurologyCan J Neurol Sci19972432002099276104
  • WilliamsAFBarclayANThe immunoglobulin superfamily – domains for cell surface recognitionAnnu Rev Immunol198863814053289571
  • LaiCWatsonJBBloomFESutcliffeJGMilnerRJNeural protein 1B236/myelin-associated glycoprotein (MAG) defines a subgroup of the immunoglobulin superfamilyImmunol Rev19871001291512450062
  • GoliasCTsoutsiEMatziridisAMakridisPBatistatouACharalabopoulosKReview. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart diseaseIn Vivo200721575776918019409
  • RieckmannPMichelUAlbrechtMBruckWWockelLFelgenhauerKSoluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cellsJ Neuroimmunol1995601–29157642752
  • FrankMKemlerRProtocadherinsCurr Opin Cell Biol200214555756212231349
  • ArikkathJReichardtLFCadherins and catenins at synapses: roles in synaptogenesis and synaptic plasticityTrends Neurosci200831948749418684518
  • KopanRIlaganMXγ-Secretase: proteasome of the membrane?Nat Rev Mol Cell Biol20045649950415173829
  • HymanBTTrojanowskiJQConsensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer diseaseJ Neuropathol Exp Neurol19975610109510979329452
  • HardyJAHigginsGAAlzheimer’s disease: the amyloid cascade hypothesisScience199225650541841851566067
  • CitronMAlzheimer’s disease: strategies for disease modificationNat Rev Drug Discov20109538739820431570
  • BertramLLillCMTanziREThe genetics of Alzheimer disease: back to the futureNeuron201068227028120955934
  • CorderEHSaundersAMStrittmatterWJGene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset familiesScience199326151239219238346443
  • HoltzmanDMBalesKRTenkovaTApolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s diseaseProc Natl Acad Sci U S A20009762892289710694577
  • LeeYJHanSBNamSYOhKWHongJTInflammation and Alzheimer’s diseaseArch Pharm Res201033101539155621052932
  • EikelenboomPvan ExelEHoozemansJJVeerhuisRRozemullerAJvan GoolWANeuroinflammation – an early event in both the history and pathogenesis of Alzheimer’s diseaseNeurodegener Dis201071–3384120160456
  • RojoLEFernandezJAMaccioniAAJimenezJMMaccioniRBNeuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer’s diseaseArch Med Res200839111618067990
  • de la TorreJCVascular basis of Alzheimer’s pathogenesisAnn N Y Acad Sci200297719621512480752
  • BretelerMMVascular risk factors for Alzheimer’s disease: an epidemiologic perspectiveNeurobiol Aging200021215316010867200
  • LoveSMinersSPalmerJChalmersKKehoePInsights into the pathogenesis and pathogenicity of cerebral amyloid angiopathyFront Biosci20091447784792
  • OndrejcakTKlyubinIHuNWBarryAECullenWKRowanMJAlzheimer’s disease amyloid beta-protein and synaptic functionNeuromolecular Med2010121132619757208
  • RupsinghRBorrieMSmithMWellsJLBarthaRReduced hippocampal glutamate in Alzheimer diseaseNeurobiol Aging201132580281019501936
  • SimsNRBowenDMAllenSJPresynaptic cholinergic dysfunction in patients with dementiaJ Neurochem19834025035096822833
  • BennettDASchneiderJAWilsonRSBieniasJLArnoldSENeurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive functionArch Neurol200461337838415023815
  • McKhannGMKnopmanDSChertkowHThe diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s diseaseAlzheimers Dement20117326326921514250
  • DeKoskySTScheffSWSynapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severityAnn Neurol19902754574642360787
  • TerryRDMasliahESalmonDPPhysical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairmentAnn Neurol19913045725801789684
  • MasliahEMalloryMAlfordMAltered expression of synaptic proteins occurs early during progression of Alzheimer’s diseaseNeurology200156112712911148253
  • ScheffSWPriceDASchmittFADeKoskySTMufsonEJSynaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairmentNeurology200768181501150817470753
  • RodriguezJJVerkhratskyANeurogenesis in Alzheimer’s diseaseJ Anat20112191788921323664
  • ErikssonPSPerfilievaEBjork-ErikssonTNeurogenesis in the adult human hippocampusNat Med1998411131313179809557
  • Alvarez-BuyllaAGarcia-VerdugoJMNeurogenesis in adult subventricular zoneJ Neurosci200222362963411826091
  • MikkonenMSoininenHTapiolaTAlafuzoffIMiettinenRHippocampal plasticity in Alzheimer’s disease: changes in highly polysialylated NCAM immunoreactivity in the hippocampal formationEur J Neurosci19991151754176410215928
  • JinKPeelALMaoXOIncreased hippocampal neurogenesis in Alzheimer’s disease. Proc Natl Acad Sci U S A620041011343347
  • AisaBGil-BeaFJSolasMAltered NCAM expression associated with the cholinergic system in Alzheimer’s diseaseJ Alzheimers Dis201020265966820164549
  • YewDTLiWPWebbSELaiHWZhangLNeurotransmitters, peptides, and neural cell adhesion molecules in the cortices of normal elderly humans and Alzheimer patients: a comparisonExp Gerontol199934111713310197733
  • FazeliMSBreenKErringtonMLBlissTVIncrease in extracellular NCAM and amyloid precursor protein following induction of long-term potentiation in the dentate gyrus of anaesthetized ratsNeurosci Lett19941691–277808047297
  • YinGNLeeHWChoJYSukKNeuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseasesBrain Res2009126515817019368810
  • StrekalovaHBuhmannCKleeneRElevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromesNeurobiol Aging20062711916298234
  • MiuraMAsouHKobayashiMUyemuraKFunctional expression of a full-length cDNA coding for rat neural cell adhesion molecule L1 mediates homophilic intercellular adhesion and migration of cerebellar neuronsJ Biol Chem19922671510752107581587850
  • GiagtzoglouNLyCVBellenHJCell adhesion, the backbone of the synapse: “vertebrate” and “invertebrate” perspectivesCold Spring Harb Perspect Biol200914a00307920066100
  • UemuraKKuzuyaAAoyagiNAmyloid beta inhibits ectodomain shedding of N-cadherin via down-regulation of cell-surface NMDA receptorNeuroscience2007145151017257767
  • KongLNZuoPPMuLLiuYYYangNGene expression profile of amyloid beta protein-injected mouse model for Alzheimer diseaseActa Pharmacol Sin200526666667215916731
  • AndoKUemuraKKuzuyaAN-cadherin regulates p38 MAPK signaling via association with JNK-associated leucine zipper protein: implications for neurodegeneration in Alzheimer diseaseJ Biol Chem201128697619762821177868
  • HerlaarEBrownZp38 MAPK signalling cascades in inflammatory diseaseMol Med Today199951043944710498912
  • HeiligEAXiaWShenJKelleherRJ3rdA presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activityJ Biol Chem201028529223502235920460383
  • MarambaudPWenPHDuttAA CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutationsCell2003114563564513678586
  • SauraCAValeroJThe role of CREB signaling in Alzheimer’s disease and other cognitive disordersRev Neurosci201122215316921476939
  • KouchiZBarthetGSerbanGGeorgakopoulosAShioiJRobakisNKp120 catenin recruits cadherins to gamma-secretase and inhibits production of Abeta peptideJ Biol Chem200928441954196119008223
  • UemuraKKuzuyaAShimohamaSProtein trafficking and Alzheimer’s diseaseCurr Alzheimer Res20041111015975080
  • RowanMJKlyubinIWangQHuNWAnwylRSynaptic memory mechanisms: Alzheimer’s disease amyloid beta-peptide-induced dysfunctionBiochem Soc Trans200735Pt 51219122317956317
  • Van GoolDCarmelietGTriauECassimanJJDomRAppearance of localized immunoreactivity for the alpha 4 integrin subunit and for fibronectin in brains from Alzheimer’s, Lewy body dementia patients and aged controlsNeurosci Lett1994170171738041517
  • AkiyamaHKawamataTDedharSMcGeerPLImmunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissueJ Neuroimmunol199132119281705945
  • CaltagaroneJHamiltonRLMurdochGJingZDeFrancoDBBowserRPaxillin and hydrogen peroxide-inducible clone 5 expression and distribution in control and Alzheimer disease hippocampiJ Neuropathol Exp Neurol201069435637120448481
  • CaltagaroneJJingZBowserRFocal adhesions regulate Abeta signaling and cell death in Alzheimer’s diseaseBiochim Biophys Acta20071772443844517215111
  • BozzoCGraziolaFChiocchettiACanonicoPLEstrogen and beta-amyloid toxicity: role of integrin and PI3-KMol Cell Neurosci2010452859120538057
  • MatterMLZhangZNordstedtCRuoslahtiEThe alpha5beta1 integrin mediates elimination of amyloid-beta peptide and protects against apoptosisJ Cell Biol19981414101910309585419
  • KoenigsknechtJLandrethGMicroglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanismJ Neurosci200424449838984615525768
  • MandrekarSJiangQLeeCYKoenigsknecht-TalbooJHoltzmanDMLandrethGEMicroglia mediate the clearance of soluble Abeta through fluid phase macropinocytosisJ Neurosci200929134252426219339619
  • Asada-UtsugiMUemuraKNodaYN-cadherin enhances APP dimerization at the extracellular domain and modulates Aβ productionJ Neurochem2011119235436321699541
  • UemuraKLillCMBanksMN-cadherin-based adhesion enhances Abeta release and decreases Abeta42/40 ratioJ Neurochem2009108235036019046403
  • ShapiroLLoveJColmanDRAdhesion molecules in the nervous system: structural insights into function and diversityAnnu Rev Neurosci20073045147417600523
  • FiederlingAEwertRAndreyevaAJunglingKGottmannKE-cadherin is required at GABAergic synapses in cultured cortical neuronsNeurosci Lett2011501316717221782891
  • TangLHungCPSchumanEMA role for the cadherin family of cell adhesion molecules in hippocampal long-term potentiationNeuron1998206116511759655504
  • AgiostratidouGMurosRMShioiJMarambaudPRobakisNKThe cytoplasmic sequence of E-cadherin promotes non-amyloidogenic degradation of A beta precursorsJ Neurochem20069641182118816417575
  • EngelhardtBImmune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. J Neurol Sci1520082741–22326
  • D’AbacoGMKayeAHIntegrins: molecular determinants of glioma invasionJ Clin Neurosci200714111041104817954373
  • BaramiKLewis-TuffinLAnastasiadisPZThe role of cadherins and catenins in gliomagenesisNeurosurg Focus2006214E13
  • BrankinBHartMNCosbySLFabryZAllenIVAdhesion molecule expression and lymphocyte adhesion to cerebral endothelium: effects of measles virus and herpes simplex 1 virusJ Neuroimmunol1995561187822475
  • OuRZhangMHuangLFlavellRAKoniPAMoskophidisDRegulation of immune response and inflammatory reactions against viral infection by VCAM-1J Virol20088262952296518216105
  • SassevilleVGLaneJHWalshDRinglerDJLacknerAAVCAM-1 expression and leukocyte trafficking to the CNS occur early in infection with pathogenic isolates of SIVJ Med Primatol19952431231318751051
  • SassevilleVGNewmanWBrodieSJHesterbergPPauleyDRinglerDJMonocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/alpha 4 beta 1 integrin interactionsAm J Pathol1994144127407507300
  • WongDDorovini-ZisKUpregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharideJ Neuroimmunol1992391–211211352310
  • GiriRShenYStinsMbeta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1Am J Physiol Cell Physiol20002796C1772C178111078691
  • GreenwoodJEtienne-MannevilleSAdamsonPCouraudPOLymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrierVascul Pharmacol200238631532212529926
  • KalinowskaALosyJPECAM-1, a key player in neuroinflammationEur J Neurol200613121284129017116209
  • RieckmannPNunkeKBurchhardtMSoluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrierJ Neuroimmunol19934721331408103775
  • LeeSJBenvenisteENAdhesion molecule expression and regulation on cells of the central nervous system. J Neuroimmunol319999827788
  • RentzosMMichalopoulouMNikolaouCSerum levels of soluble intercellular adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1 in Alzheimer’s diseaseJ Geriatr Psychiatry Neurol200417422523115533994
  • RentzosMMichalopoulouMNikolaouCThe role of soluble intercellular adhesion molecules in neurodegenerative disorders. J Neurol Sci1520052282129135
  • EngelhartMJGeerlingsMIMeijerJInflammatory proteins in plasma and the risk of dementia: the Rotterdam studyArch Neurol200461566867215148142
  • NielsenHMLondosEMinthonLJanciauskieneSMSoluble adhesion molecules and angiotensin-converting enzyme in dementiaNeurobiol Dis2007261273517270454
  • ZulianiGCavalieriMGalvaniMMarkers of endothelial dysfunction in older subjects with late onset Alzheimer’s disease or vascular dementiaJ Neurol Sci20082721–216417018597785
  • EikelenboomPZhanSSKamphorstWvan der ValkPRozemullerJMCellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer’s diseaseVirchows Arch199442444214277515758
  • FrohmanEMFrohmanTCGuptaSde FougerollesAvan den NoortSExpression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer’s diseaseJ Neurol Sci199110611051111685745
  • RozemullerJMEikelenboomPPalsSTStamFCMicroglial cells around amyloid plaques in Alzheimer’s disease express leucocyte adhesion molecules of the LFA-1 familyNeurosci Lett198910132882922549464
  • NielsenHMPalmqvistSMinthonLLondosEWennstromMGender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementiaCurr Alzheimer Res20129325726622191565
  • EikelenboomPRozemullerAJHoozemansJJVeerhuisRvan GoolWANeuroinflammation and Alzheimer disease: clinical and therapeutic implicationsAlzheimer Dis Assoc Disord200014Suppl 1S54S6110850731
  • HoggNPatzakIWillenbrockFThe insider’s guide to leukocyte integrin signalling and functionNat Rev Immunol201111641642621597477
  • BambergerMEHarrisMEMcDonaldDRHusemannJLandrethGEA cell surface receptor complex for fibrillar beta-amyloid mediates microglial activationJ Neurosci20032372665267412684452
  • NeniskyteUNeherJJBrownGCNeuronal death induced by nanomolar amyloid beta is mediated by primary phagocytosis of neurons by microgliaJ Biol Chem201128646399043991321903584
  • AkiyamaHMcGeerPLBrain microglia constitutively express beta-2 integrinsJ Neuroimmunol199030181931977769
  • RyuJKMcLarnonJGA leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brainJ Cell Mol Med2009139A2911292518657226
  • HalleskogCMulderJDahlstromJWNT signaling in activated microglia is proinflammatoryGlia201159111913120967887
  • BorroniBVolpiRMartiniGPeripheral blood abnormalities in Alzheimer disease: evidence for early endothelial dysfunctionAlzheimer Dis Assoc Disord200216315015512218645
  • RentzosMMichalopoulouMNikolaouCSerum levels of soluble intercellular adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1 in Alzheimer’s diseaseJ Geriatr Psychiatry Neurol200417422523115533994
  • RosenbergRNBaskinFFosmireJAAltered amyloid protein processing in platelets of patients with Alzheimer diseaseArch Neurol19975421391449041854
  • BorroniBColciaghiFPastorinoLApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral modelEur Neuropsychopharmacol200212319520012007670
  • StellosKPanagiotaVKogelALeyheTGawazMLaskeCPredictive value of platelet activation for the rate of cognitive decline in Alzheimer’s disease patientsJ Cereb Blood Flow Metab201030111817182020717123
  • JaremoPMilovanovicMBullerCNilssonSWinbladBLow-density platelet populations demonstrate low in vivo activity in sporadic Alzheimer diseasePlatelets201223211612022150375
  • WoollardKJChin-DustingJP-selectin antagonism in inflammatory diseaseCurr Pharm Des201016374113411821247396
  • BeerAJSchwaigerMImaging of integrin alphavbeta3 expressionCancer Metastasis Rev200827463164418523730
  • DesaiBSSchneiderJALiJLCarveyPMHendeyBEvidence of angiogenic vessels in Alzheimer’s diseaseJ Neural Transm2009116558759719370387
  • GrammasPSanchezATripathyDLuoEMartinezJVascular signaling abnormalities in Alzheimer diseaseCleve Clin J Med201178Suppl 1S50S5321972332
  • FrancisPTPalmerAMSnapeMWilcockGKThe cholinergic hypothesis of Alzheimer’s disease: a review of progressJ Neurol Neurosurg Psychiatry199966213714710071091
  • BarKJBoettgerMKSeidlerNMentzelHJTerborgCSauerHInfluence of galantamine on vasomotor reactivity in Alzheimer’s disease and vascular dementia due to cerebral microangiopathyStroke200738123186319217962592
  • RosengartenBLutzHKapsMThe neurovascular coupling bears properties of a feedforward and feedback regulative mechanismUltrasound Med Biol20083411617720302
  • RosengartenBPaulsenSMolnarSKaschelRGallhoferBKapsMAcetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patientsJ Neurol20062531586416096820
  • HwangJHwangHLeeHWSukKMicroglia signaling as a target of donepezilNeuropharmacology20105871122112920153342
  • YoshiyamaYKojimaAIshikawaCAraiKAnti-inflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse modelJ Alzheimers Dis201022129530620847440
  • OsbornGGSaundersAVCurrent treatments for patients with Alzheimer diseaseJ Am Osteopath Assoc20101109 Suppl 8S16S2620926739
  • RosiSRamirez-AmayaVVazdarjanovaAAccuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine. BrainSep2009132Pt 924642477
  • PaulCBoltonCModulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-D-aspartate receptor antagonist memantineJ Pharmacol Exp Ther20023021505712065699
  • BordjiKBecerril-OrtegaJBuissonASynapses, NMDA receptor activity and neuronal Abeta production in Alzheimer’s diseaseRev Neurosci201122328529421568789
  • RayBBanerjeePKGreigNHLahiriDKMemantine treatment decreases levels of secreted Alzheimer’s amyloid precursor protein (APP) and amyloid beta (A beta) peptide in the human neuroblastoma cellsNeurosci Lett201047011519948208
  • HarkanyTHortobagyiTSasvariMNeuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer’s diseaseProg Neuropsychopharmacol Biol Psychiatry1999236963100810621945
  • in’t VeldBARuitenbergAHofmanANonsteroidal antiinflammatory drugs and the risk of Alzheimer’s diseaseN Engl J Med2001345211515152111794217
  • WattmoCWallinAKLondosEMinthonLPredictors of long-term cognitive outcome in Alzheimer’s diseaseAlzheimers Res Ther2011342321774798
  • BreitnerJCBakerLDMontineTJExtended results of the Alzheimer’s disease anti-inflammatory prevention trialAlzheimers Dement20117440241121784351
  • RossiBConstantinGAnti-selectin therapy for the treatment of inflammatory diseasesInflamm Allergy Drug Targets200872859318691137
  • VerbeekMMOtte-HollerIWesselingPRuiterDJde WaalRMDifferential expression of intercellular adhesion molecule-1 (ICAM-1) in the A beta-containing lesions in brains of patients with dementia of the Alzheimer typeActa Neuropathol19969166086158781660
  • VerbeekMMOtte-HollerIWestphalJRWesselingPRuiterDJde WaalRMAccumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer’s diseaseAm J Pathol199414411041167904796
  • CaoJShiXLiWLiuJMiaoXXuJProtective effect of anti-intercellular adhesion molecule-1 antibody on global cerebral ischemia/reperfusion injury in the ratBiosci Trends200932485220103946
  • KanemotoYNakaseHAkitaNSakakiTEffects of anti-intercellular adhesion molecule-1 antibody on reperfusion injury induced by late reperfusion in the rat middle cerebral artery occlusion modelNeurosurgery200251410341041 discussion 1041–104212234414
  • JanciauskieneSMEriksonCWarkentinSA link between sICAM-1, ACE and parietal blood flow in the aging brainNeurobiol Aging20093091504151118243419
  • BaileyJARayBGreigNHLahiriDKRivastigmine lowers Abeta and increases sAPPalpha levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neuronsPLoS One201167e2195421799757
  • HaasCStrategies, development, and pitfalls of therapeutic options for Alzheimer’s diseaseJ Alzheimers Dis201228224128121987594
  • BocheDZotovaEWellerROConsequence of Abeta immunization on the vasculature of human Alzheimer’s disease brainBrain2008131Pt 123299331018953056
  • EngelhardtBThe blood-central nervous system barriers actively control immune cell entry into the central nervous systemCurr Pharm Des200814161555156518673197
  • LebsonLNashKKamathSTrafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic miceJ Neurosci201030299651965820660248
  • Fateh-MoghadamSHtunPTomandlBHyperresponsiveness of platelets in ischemic strokeThromb Haemost200797697497817549300
  • StellosKBigalkeBStakosDHenkelmannNGawazMPlatelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medicationJ Thromb Haemost20108120520719874461
  • AkiyamaHMcGeerPLBrain microglia constitutively express beta-2 integrinsJ Neuroimmunol199030181931977769